Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Cervical Cancer, February 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 356 articles:
HTML format


 

Single Articles

  1. SALUTARI V, Gagliardi M, Rizzatti G, Ciccarone F, et al
    Endoscopic ultrasound-guided radiofrequency ablation of recurrent cervical cancer in the pelvis untreatable by radiation therapy.
    Endoscopy. 2022 Feb 4. doi: 10.1055/a-1730-4346.
    PubMed    


  2. STRELOW B, O'Laughlin D
    Barriers to cervical cancer screening among immigrants.
    JAAPA. 2022 Feb 2. pii: 01720610-900000000-99636.
    PubMed    
    Abstract available

  3. LIU MC, Tewari KS
    Current and emerging immunotherapies for recurrent cervical cancer.
    Clin Adv Hematol Oncol. 2022;20:108-115.
    PubMed    
    Abstract available

  4. SPEER L, Bodi S
    Cervical cancer update: The latest on screening & management.
    J Fam Pract. 2021;70:499-509.
    PubMed    
    Abstract available

  5. ZHANG Q, Guo J, Ouyang H, Chen S, et al
    Correction to: Added-value of dynamic contrast-enhanced MRI on prediction of tumor recurrence in locally advanced cervical cancer treated with chemoradiotherapy.
    Eur Radiol. 2022 Feb 4. pii: 10.1007/s00330-022-08543.
    PubMed    


  6. YANG X, Huang L, Li C, Ji N, et al
    The effectiveness of mindfulness-based stress reduction intervention on alleviating anxiety and depression in postoperative patients with cervical cancer: A protocol for systematic review and meta-analysis.
    Medicine (Baltimore). 2022;101:e28706.
    PubMed    
    Abstract available

  7. PAN L, Jia X, Zhao X, Zhang B, et al
    Study on the correlation between energy spectrum computed tomography imaging and the pathological characteristics and prognosis of cervical cancer.
    Transl Cancer Res. 2021;10:4096-4105.
    PubMed    
    Abstract available

  8. GUI Y, Wang L, Huang Z
    MiR-137 inhibits cervical cancer progression via down-modulating Notch1 and inhibiting the PI3K/AKT/mTOR signaling pathway.
    Transl Cancer Res. 2021;10:3748-3756.
    PubMed    
    Abstract available

  9. PING Q, Zeng J, Sun P, Qu P, et al
    Efficacy of preoperative brachytherapy for controlling vaginal bleeding in early-stage cervical cancer: a retrospective study.
    Transl Cancer Res. 2021;10:3259-3267.
    PubMed    
    Abstract available

  10. YU R, Zhang L, Yu Q, Zhao H, et al
    Effect of LHX2 gene methylation level and its function on radiotherapy of cervical cancer.
    Transl Cancer Res. 2021;10:2944-2961.
    PubMed    
    Abstract available

  11. WANG W, Gao X, Zhu Y, Qi Y, et al
    Diagnostic significance of a color Doppler ultrasound combined with serum CXCL16 and E-cad in cervical cancer.
    Transl Cancer Res. 2021;10:1492-1499.
    PubMed    
    Abstract available

  12. ZHANG W, Li X, Lin T, Ma F, et al
    A model to guide the management and decision of re-planning during radiotherapy for cervical cancer.
    Transl Cancer Res. 2021;10:5352-5363.
    PubMed    
    Abstract available

  13. DAI S, Yao D
    An immune-associated ten-long noncoding RNA signature for predicting overall survival in cervical cancer.
    Transl Cancer Res. 2021;10:5295-5306.
    PubMed    
    Abstract available

  14. YUAN Y, Chang XB, Hu LJ, Wang GQ, et al
    Effect of isocenter deviation on volume modulated arc therapy plan results and gamma passing rate in the treatment of cervical cancer.
    Transl Cancer Res. 2021;10:4403-4412.
    PubMed    
    Abstract available

  15. ZHANG X, Chen Z, Chen J, Wang J, et al
    Surgery followed by concurrent radiochemotherapy as treatment for patients with locally recurrent cervical cancer.
    Transl Cancer Res. 2021;10:4365-4374.
    PubMed    
    Abstract available

  16. LI M, Tian Q
    Risk factors for postoperative pelvic floor dysfunction in patients with cervical cancer: evidences for management strategies.
    Transl Cancer Res. 2021;10:4338-4346.
    PubMed    
    Abstract available

  17. LUO W, Li Y, Ke G, Wu X, et al
    Extended field or pelvic intensity-modulated radiotherapy with concurrent cisplatin chemotherapy for the treatment of post-surgery multiple pelvic lymph node metastases in cervical cancer patients: a randomized, multi-center phase II clinical trial.
    Transl Cancer Res. 2021;10:361-371.
    PubMed    
    Abstract available

  18. KE Y, Zu S, Chen L, Liu M, et al
    Combination of Estrogen Receptor Alpha and Histological Type Helps to Predict Lymph Node Metastasis in Patients with Stage IA2 to IIA2 Cervical Cancer.
    Cancer Manag Res. 2022;14:317-325.
    PubMed    
    Abstract available

  19. FUJITA M, Shimazu M, Nagashima K, Suzuki M, et al
    Study protocol of the ACCESS trial: a randomised trial to evaluate the effectiveness of human papillomavirus testing by self-sampling in cervical cancer screening uptake and precancer detection.
    BMJ Open. 2022;12:e049803.
    PubMed    
    Abstract available

  20. CAO X, Yao J, Jia M, Shen X, et al
    Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer.
    J Ovarian Res. 2022;15:20.
    PubMed    
    Abstract available

  21. TEKALEGN Y, Sahiledengle B, Woldeyohannes D, Atlaw D, et al
    High parity is associated with increased risk of cervical cancer: Systematic review and meta-analysis of case-control studies.
    Womens Health (Lond). 2022;18:17455065221075904.
    PubMed    
    Abstract available

  22. DEVI S
    MSF breast and cervical cancer screening programmes in Mali and Malawi.
    Lancet Oncol. 2022;23:207-208.
    PubMed    


  23. GARCIA A, Juarez M, Sacuj N, Tzurec E, et al
    Loss to Follow-Up and the Care Cascade for Cervical Cancer Care in Rural Guatemala: A Cross-Sectional Study.
    JCO Glob Oncol. 2022;8:e2100286.
    PubMed    
    Abstract available

  24. SU Y, Hou W, Zhang C, Ji P, et al
    Long non-coding RNA ZFAS1 regulates cell proliferation and invasion in cervical cancer via the miR-190a-3p/KLF6 axis.
    Bioengineered. 2022;13:3840-3851.
    PubMed    
    Abstract available

  25. CALDERON-MORA J, Alomari A, Shokar N
    Comparison of Narrative Video and Flipchart Presentation to Promote Cervical Cancer Screening Among Latinas Along the Border.
    Health Educ Behav. 2022 Feb 3:10901981221074918. doi: 10.1177/10901981221074918.
    PubMed    
    Abstract available

  26. MANDAI M, Yamaguchi K, Hamanishi J, Sekiyama K, et al
    Superradical Hysterectomy for Cervical Cancer as an Alternative to the Usual Okabayashi-Type Radical Hysterectomy.
    Surg J (N Y). 2021;7.
    PubMed    
    Abstract available

  27. NARAYANAN S, Biju P, Sundaramoorthy S, Rajaraman V, et al
    A Unique Finding of Hepatogastric Fistula in Cervical Cancer Liver Metastasis.
    Cureus. 2021;13:e20761.
    PubMed    
    Abstract available

  28. ZHANG H, Zhang Y, Cao J, Ma L, et al
    Stable high-oxidation-state complex in situ Mn(V)-Mn(III) transition to achieve highly efficient cervical cancer therapy.
    Chem Commun (Camb). 2022 Feb 1. doi: 10.1039/d1cc06819.
    PubMed    
    Abstract available

  29. SUBBA SH, Parida SP, Sahu DP, Kumari J, et al
    Knowledge and attitude towards, and the utilisation of cervical and breast cancer screening services by female healthcare professionals at a tertiary care hospital of Eastern India: A cross-sectional study.
    Niger Postgrad Med J. 2022;29:63-69.
    PubMed    
    Abstract available

  30. ITAMI J, Murakami N, Watanabe M, Sekii S, et al
    Combined Interstitial and Intracavitary High-Dose Rate Brachytherapy of Cervical Cancer.
    Front Oncol. 2022;11:809825.
    PubMed    
    Abstract available

  31. HUANG G, Cui Y, Wang P, Ren J, et al
    Multi-Parametric Magnetic Resonance Imaging-Based Radiomics Analysis of Cervical Cancer for Preoperative Prediction of Lymphovascular Space Invasion.
    Front Oncol. 2022;11:663370.
    PubMed    
    Abstract available

  32. YANG J, Hai J, Dong X, Zhang M, et al
    MicroRNA-92a-3p Enhances Cisplatin Resistance by Regulating Kruppel-Like Factor 4-Mediated Cell Apoptosis and Epithelial-to-Mesenchymal Transition in Cervical Cancer.
    Front Pharmacol. 2022;12:783213.
    PubMed    
    Abstract available

  33. YANG L, Xu Z, Ma L, Liu Q, et al
    Early onset of severe lymphopenia during definitive radiotherapy correlates with mean body dose and predicts poor survival in cervical cancer.
    Cancer Biomark. 2022 Jan 14. pii: CBM210292. doi: 10.3233/CBM-210292.
    PubMed    
    Abstract available

  34. GAUCI PA, Kee DLC, Thamphya B, Schiappa R, et al
    Preoperative high-dose-rate brachytherapy for high-risk early-stage cervical cancer: Long-term clinical outcome analysis.
    Brachytherapy. 2022 Jan 27. pii: S1538-4721(21)00540.
    PubMed    
    Abstract available

  35. YOGANATHAN SA, Paul SN, Paloor S, Torfeh T, et al
    Automatic segmentation of MR images for high-dose-rate cervical cancer brachytherapy using deep learning.
    Med Phys. 2022 Jan 30. doi: 10.1002/mp.15506.
    PubMed    
    Abstract available

  36. REN L, Yang J, Meng X, Zhang J, et al
    The promotional effect of microRNA-103a-3p in cervical cancer cells by regulating the ubiquitin ligase FBXW7 function.
    Hum Cell. 2022 Jan 30. pii: 10.1007/s13577-021-00649.
    PubMed    
    Abstract available

  37. CSECSEI K, Csehely S, Poka R, Zadori Z, et al
    Hemangioma of the uterine cervix: report of four cases and review of the literature.
    Orv Hetil. 2022;163:187-194.
    PubMed    
    Abstract available

  38. DELRUE C, Vanwalleghem L, Paepe P, Trappen PV, et al
    Stratified Mucin-producing Intraepithelial Lesions of the Cervix: Clinical Diversity of Cases and Literature Review.
    Anticancer Res. 2022;42:1175-1180.
    PubMed    
    Abstract available

  39. XIE Q, Li Z, Luo X, Wang D, et al
    piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner.
    J Transl Med. 2022;20:51.
    PubMed    
    Abstract available

  40. FISCHER ACP, Fischer EAP, Vaz FB, Hoffmann J, et al
    Analysis of the Excess of Papanicolaou Tests in Brazil from 2006 to 2015.
    Rev Bras Ginecol Obstet. 2022;44:40-46.
    PubMed    
    Abstract available

  41. BOSE CK
    Balstilimab and other immunotherapy for recurrent and metastatic cervical cancer.
    Med Oncol. 2022;39:47.
    PubMed    
    Abstract available

  42. REN J, Li Y, Yang JJ, Zhao J, et al
    MRI-based radiomics analysis improves preoperative diagnostic performance for the depth of stromal invasion in patients with early stage cervical cancer.
    Insights Imaging. 2022;13:17.
    PubMed    
    Abstract available

  43. YADAV P, Vats R, Bano A, Vashishtha A, et al
    A Phytochemicals Approach Towards the Treatment of Cervical Cancer Using Polyphenols and Flavonoids.
    Asian Pac J Cancer Prev. 2022;23:261-270.
    PubMed    
    Abstract available

  44. YUSUF H, Fahriani M, Murzalina C
    Anti Proliferative and Apoptotic Effect of Soluble Ethyl Acetate Partition from Ethanol Extract of Chromolaena Odorata Linn Leaves Against Hela Cervical Cancer Cell line.
    Asian Pac J Cancer Prev. 2022;23:183-189.
    PubMed    
    Abstract available

  45. SAVIRA M, S D, Putra AE, Yusrawati Y, et al
    Detecting Human Papillomavirus Type 16 in Cervical Cancer Patients with Molecular Variation of Gene L1 in Riau Province Indonesia.
    Asian Pac J Cancer Prev. 2022;23:87-92.
    PubMed    
    Abstract available

  46. LIAO D, Liu X, Yuan X, Feng P, et al
    Long non-coding RNA tumor protein 53 target gene 1 promotes cervical cancer development via regulating microRNA-33a-5p to target forkhead box K2.
    Cell Cycle. 2022 Jan 28:1-13. doi: 10.1080/15384101.2022.2026705.
    PubMed    
    Abstract available

  47. WAGNER W, Sobierajska K, Kania KD, Paradowska E, et al
    Lactate Suppresses Retroviral Transduction in Cervical Epithelial Cells through DNA-PKcs Modulation.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  48. MIX JM, Saraiya M, Senkomago V, Unger ER, et al
    High-Grade Vulvar, Vaginal, and Anal Precancers Among U.S. Adolescents and Young Adults After Human Papillomavirus Vaccine Introduction.
    Am J Prev Med. 2022;62:95-99.
    PubMed    
    Abstract available

  49. HSIAO YH, Chen PN, Hsin MC, Wang PH, et al
    The risk of distant metastases in patients with gynecologic cancers after surgery: a population-based study.
    Aging (Albany NY). 2021;13:25846-25858.
    PubMed    
    Abstract available

  50. ANINYE IO, Berry-Lawhorn JM, Blumenthal P, Felder T, et al
    Gaps and Opportunities to Improve Prevention of Human Papillomavirus-Related Cancers.
    J Womens Health (Larchmt). 2021;30:1667-1672.
    PubMed    
    Abstract available

  51. GAJSEK US, Dovnik A, Takac I, Ivanus U, et al
    Diagnostic performance of p16/Ki-67 dual immunostaining at different number of positive cells in cervical smears in women referred for colposcopy.
    Radiol Oncol. 2021;55:426-432.
    PubMed    
    Abstract available

  52. DU XT, Wang XY, Zheng YH, Liu DP, et al
    Propofol suppresses the growth and invasion of cervical carcinoma cells by inhibiting MIR155HG.
    Aging (Albany NY). 2021;13:24464-24475.
    PubMed    
    Abstract available

  53. PUNYASHTHIRA A, Horthongkham N, Jaishuen A, Jareemit N, et al
    A comparison of high-risk human papillomavirus DNA detection between urine and cervical sample testing in women with abnormal Pap smears.
    J Obstet Gynaecol Res. 2022;48:448-455.
    PubMed    
    Abstract available

  54. MOHD NAFIS NS, Mat Zin AA
    Evaluation of PathTezt, a Liquid-Based Cytology System.
    Asian Pac J Cancer Prev. 2021;22:3261-3266.
    PubMed    
    Abstract available

  55. KIM JM, Yang YS, Lee SH, Jee SH, et al
    Association between Early Menopause, Gynecological Cancer, and Tobacco Smoking: A Cross-Sectional Study.
    Asian Pac J Cancer Prev. 2021;22:3165-3170.
    PubMed    
    Abstract available

  56. MATALLIOTAKIS M, Matalliotaki C, Zervou MI, Krithinakis K, et al
    Coexistence of cervical endometriosis with premalignant and malignant gynecological pathologies: report on a series of 27 cases.
    Women Health. 2021;61:896-901.
    PubMed    
    Abstract available

  57. HUGUET N, Hodes T, Holderness H, Bailey SR, et al
    Community Health Centers' Performance in Cancer Screening and Prevention.
    Am J Prev Med. 2022;62:e97-e106.
    PubMed    
    Abstract available

  58. REGAUER S, Reich O
    The origin of Human Papillomavirus (HPV) - induced cervical squamous cancer.
    Curr Opin Virol. 2021;51:111-118.
    PubMed    
    Abstract available

  59. NIEVES-RAMIREZ ME, Partida-Rodriguez O, Moran P, Serrano-Vazquez A, et al
    Cervical Squamous Intraepithelial Lesions Are Associated with Differences in the Vaginal Microbiota of Mexican Women.
    Microbiol Spectr. 2021;9:e0014321.
    PubMed    
    Abstract available

  60. LIU S, Gu L, Wu N, Song J, et al
    Overexpression of DTL enhances cell motility and promotes tumor metastasis in cervical adenocarcinoma by inducing RAC1-JNK-FOXO1 axis.
    Cell Death Dis. 2021;12:929.
    PubMed    
    Abstract available

  61. DOORBAR J, Zheng K, Aiyenuro A, Yin W, et al
    Principles of epithelial homeostasis control during persistent human papillomavirus infection and its deregulation at the cervical transformation zone.
    Curr Opin Virol. 2021;51:96-105.
    PubMed    
    Abstract available

  62. ALSNER J, Overgaard J, Tramm T, Lindegaard JC, et al
    Hypoxic gene expression is a prognostic factor for disease free survival in a cohort of locally advanced squamous cell cancer of the uterine cervix.
    Acta Oncol. 2022;61:172-178.
    PubMed    
    Abstract available

  63. JIANG Q, Yue S, Yu K, Tian T, et al
    Endogenous microRNA triggered enzyme-free DNA logic self-assembly for amplified bioimaging and enhanced gene therapy via in situ generation of siRNAs.
    J Nanobiotechnology. 2021;19:288.
    PubMed    
    Abstract available

  64. DARLING HS, Jaiswal P, Lohia N, Tiwari NR, et al
    MCQs on "Feasibility, uptake and real-life challenges of a rural cervical and breast cancer screening program in Vellore, Tamil Nadu, South India".
    Indian J Cancer. 2021;58:425-427.
    PubMed    


  65. SHANG H, Jang X, Shi L, Ma Y, et al
    Lycorine inhibits cell proliferation and induced oxidative stress-mediated apoptosis via regulation of the JAK/STAT3 signaling pathway in HT-3 cells.
    J Biochem Mol Toxicol. 2021;35:e22882.
    PubMed    
    Abstract available

  66. SHI Z, Qu X, Guo C, Zhang L, et al
    Identification of clinical trait-related small RNA biomarkers with weighted gene co-expression network analysis for personalized medicine in endocervical adenocarcinoma.
    Aging (Albany NY). 2021;13:22361-22374.
    PubMed    
    Abstract available

  67. HORNER PJ, Flanagan H, Horne AW
    Is There a Hidden Burden of Disease as a Result of Epigenetic Epithelial-to-Mesenchymal Transition Following Chlamydia trachomatis Genital Tract Infection?
    J Infect Dis. 2021;224.
    PubMed    
    Abstract available

  68. KAYYAL M, Bolhassani A, Noormohammadi Z, Sadeghizadeh M, et al
    In Silico Design and Immunological Studies of Two Novel Multiepitope DNA-Based Vaccine Candidates Against High-Risk Human Papillomaviruses.
    Mol Biotechnol. 2021;63:1192-1222.
    PubMed    
    Abstract available

  69. IACOBONE AD, Bottari F, Guerrieri ME, Vidal Urbinati AM, et al
    The Potential Impact of High-Risk Human Papillomavirus-Negative Cervical Intraepithelial Neoplasia 2+ on Primary Human Papillomavirus Screening.
    Am J Clin Pathol. 2022;157:130-135.
    PubMed    
    Abstract available

  70. ROBERT P, Kavida AC
    Morphological Based Medical Image Processing on Cervical Cytology Cancer Images Using Connected Component Techniques.
    Curr Med Imaging. 2021;17:1439-1450.
    PubMed    
    Abstract available

  71. TATSUTA K, Harada T, Nishiwaki Y
    Cervical Skeletal Muscle Metastasis of Colorectal Cancer.
    Intern Med. 2022;61:263-264.
    PubMed    


  72. HUANG CH, Lo YJ, Kuo KM, Lu IC, et al
    Health literacy and cancer screening behaviors among community-dwelling female adults in Taiwan.
    Women Health. 2021;61:408-419.
    PubMed    
    Abstract available

  73. TUDREJ BV, Dernoncourt M, Rehman MB, Mignot S, et al
    National institutions should improve the information made available to patients about cervical smears.
    Patient Educ Couns. 2021;104:3097-3099.
    PubMed    
    Abstract available

  74. BARIK S, Mitra S, Suryavanshi M, Dewan A, et al
    To study the role of pre-treatment microRNA (micro ribonucleic acid) expression as a predictor of response to chemoradiation in locally advanced carcinoma cervix.
    Cancer Rep (Hoboken). 2021;4:e1348.
    PubMed    
    Abstract available

  75. ILIC I, Babic G, Dimitrijevic A, Ilic M, et al
    Internal consistency and validity of the Hospital Anxiety and Depression Scale (HADS) in women with abnormal Pap smear in Serbia.
    Women Health. 2021;61:363-371.
    PubMed    
    Abstract available

  76. GOETGEBUER RL, Kreijne JE, Aitken CA, Dijkstra G, et al
    Increased risk of high-grade cervical neoplasia in women with inflammatory bowel disease: a case-controlled cohort study.
    J Crohns Colitis. 2021 Feb 20. pii: 6145789. doi: 10.1093.
    PubMed    
    Abstract available

  77. QUDDUS MR, Ribeiro E Ribeiro R, Singh K
    Androgen-induced Hyperplastic Prostatic Glands in the Uterine Cervix.
    Int J Gynecol Pathol. 2022;41:e1-e2.
    PubMed    


  78. SEALY DA, Modeste N, Dyett P
    Barriers and facilitators to the HPV vaccine among mothers of adolescent girls: a qualitative study conducted in Trinidad and Tobago.
    Women Health. 2021;61:235-243.
    PubMed    
    Abstract available

  79. ZHANG X, Wang Y, Wang X, Zou B, et al
    Extracellular vesicles-encapsulated microRNA-10a-5p shed from cancer-associated fibroblast facilitates cervical squamous cell carcinoma cell angiogenesis and tumorigenicity via Hedgehog signaling pathway.
    Cancer Gene Ther. 2021;28:529-542.
    PubMed    
    Abstract available

  80. WEI H, Sun T, Liu J, Wang X, et al
    Isoflurane activates AMP-activated protein kinase to inhibit proliferation, and promote apoptosis and autophagy in cervical carcinoma both in vitro and in vivo.
    J Recept Signal Transduct Res. 2021;41:538-545.
    PubMed    
    Abstract available

  81. ZHONG L, Li K, Song L, Yin R, et al
    The effect of consolidation chemotherapy after concurrent chemoradiation on the prognosis of locally advanced cervical cancer: a systematic review and meta-analysis.
    J Obstet Gynaecol. 2022 Feb 11:1-8. doi: 10.1080/01443615.2021.2012437.
    PubMed    
    Abstract available

  82. MATEUS D, Wiedlocha A
    FGF-FGFR signaling promotes the development of invasive cervical cancer.
    FEBS J. 2022 Feb 11. doi: 10.1111/febs.16384.
    PubMed    
    Abstract available

  83. DE ALBUQUERQUE LZ, da Silva JL, Dos Santos ALS, Rodrigues IP, et al
    Prevalence of long-term opioid use after radiotherapy for cervical cancer in a Brazilian cancer center.
    J Cancer Surviv. 2022 Feb 11. pii: 10.1007/s11764-022-01183.
    PubMed    
    Abstract available

  84. DING Y, Zhang X, Qiu J, Zhang J, et al
    Assessment of ESGO Quality Indicators in Cervical Cancer Surgery: A Real-World Study in a High-Volume Chinese Hospital.
    Front Oncol. 2022;12:802433.
    PubMed    
    Abstract available

  85. LIU B, Sun Z, Xu ZL, Zhao HL, et al
    Predicting Disease-Free Survival With Multiparametric MRI-Derived Radiomic Signature in Cervical Cancer Patients Underwent CCRT.
    Front Oncol. 2022;11:812993.
    PubMed    
    Abstract available

  86. YU L, Li W
    Abnormal activation of notch 1 signaling causes apoptosis resistance in cervical cancer.
    Int J Clin Exp Pathol. 2022;15:11-19.
    PubMed    
    Abstract available

  87. YE X, Zhu B, Han J, Huang J, et al
    Circ-0036602 Acts As a Sponge of MiR-34a-5p and MiR-431-5p to Promote Cervical Cancer Proliferation and Invasion.
    J Genomics. 2022;10:16-25.
    PubMed    
    Abstract available

  88. SHEJUL J, Chopra S, Ranjan N, Mahantshetty U, et al
    Temporal course of late rectal toxicity & impact of intervention in patients undergoing radiation for cervical cancer.
    Indian J Med Res. 2022 Feb 10. pii: 337069. doi: 10.4103/ijmr.IJMR_4787.
    PubMed    
    Abstract available

  89. MUSUNURU HB, Pifer PM, Mohindra P, Albuquerque K, et al
    Advances in management of locally advanced cervical cancer.
    Indian J Med Res. 2022 Feb 10. pii: 337057. doi: 10.4103/ijmr.IJMR_1047.
    PubMed    
    Abstract available

  90. BAO H, Ma L, Zhao Y, Song B, et al
    Age-specific effectiveness of primary human papillomavirus screening versus cytology in a cervical cancer screening program: a nationwide cross-sectional study.
    Cancer Commun (Lond). 2022 Feb 10. doi: 10.1002/cac2.12256.
    PubMed    
    Abstract available

  91. MISHRA N, Singh N, Sachdeva M, Ghatage P, et al
    Sexual Dysfunction in Cervical Cancer Survivors: A Scoping Review.
    Womens Health Rep (New Rochelle). 2021;2:594-607.
    PubMed    
    Abstract available

  92. HOU Y, Dong Z, Zhong W, Yin L, et al
    FOXM1 Promotes Drug Resistance in Cervical Cancer Cells by Regulating ABCC5 Gene Transcription.
    Biomed Res Int. 2022;2022:3032590.
    PubMed    
    Abstract available

  93. JI H, Li K, Jiang W, Li J, et al
    MRVI1 and NTRK3 Are Potential Tumor Suppressor Genes Commonly Inactivated by DNA Methylation in Cervical Cancer.
    Front Oncol. 2022;11:802068.
    PubMed    
    Abstract available

  94. ZHANG M, Dai W, Si Y, Shi Y, et al
    Comparison of Minimally Invasive Versus Abdominal Radical Hysterectomy for Early-Stage Cervical Cancer: An Updated Meta-Analysis.
    Front Oncol. 2022;11:762921.
    PubMed    
    Abstract available

  95. HIRATSUKA D, Tsukazaki T, Sone K, Neriishi K, et al
    A Case of Nonpuerperal Uterine Inversion Caused by Cervical Cancer.
    Case Rep Obstet Gynecol. 2022;2022:1630192.
    PubMed    
    Abstract available

  96. MAYLAA T, Windal F, Benhabiles H, Maubon G, et al
    An evaluation of computational learning-based methods for the segmentation of nuclei in cervical cancer cells from microscopic images.
    Curr Comput Aided Drug Des. 2022 Feb 8. pii: CAD-EPUB-120749.
    PubMed    
    Abstract available

  97. LAUBY-SECRETAN B, Mackie A, Wentzensen N
    The IARC Perspective on Cervical Cancer Screening. Reply.
    N Engl J Med. 2022;386:607-608.
    PubMed    


  98. SUBA EJ, Ortega RE, Mutch DG
    The IARC Perspective on Cervical Cancer Screening.
    N Engl J Med. 2022;386:607.
    PubMed    


  99. TEWARI KS, Monk BJ, Vergote I, Miller A, et al
    Survival with Cemiplimab in Recurrent Cervical Cancer.
    N Engl J Med. 2022;386:544-555.
    PubMed    
    Abstract available

  100. OLOWOLAJU S, Kassabian M, Akinlotan MA, Lichorad A, et al
    Cervical Cancer Screening Outcomes Among a Sample of Low-Income Uninsured Women: A Program-Based Study.
    Womens Health Rep (New Rochelle). 2022;3:85-92.
    PubMed    
    Abstract available

  101. MACLAUGHLIN KL, Jacobson RM, St Sauver JL, Jenkins GD, et al
    Awareness and Support of Clinician- and Patient-Collected Human Papillomavirus Testing for Cervical Cancer Screening Among Primary Care Clinicians.
    Womens Health Rep (New Rochelle). 2022;3:10-19.
    PubMed    
    Abstract available

  102. ADOGA MP, Reuben RC, Abubakar K, Oti VB, et al
    Human papillomavirus type 16 (HPV-16) IgG antibody among women of reproductive age presenting at a healthcare facility in Central Nigeria: a pilot study.
    Pan Afr Med J. 2021;40:203.
    PubMed    
    Abstract available

  103. LIN Z, Zhao Y, Li Q, Ci X, et al
    Sustained Expression of HPV16 E7 Oncoprotein Promotes p-AKT (Ser473)/p-Src (Tyr527) Signalling to Drive Precancerous Lesions to Invasive Cervical Cancer.
    Carcinogenesis. 2022 Feb 4. pii: 6522856. doi: 10.1093.
    PubMed    
    Abstract available

  104. GULBIANI L, Topuridze M, Todua T, Sarashvili N, et al
    AWARENESS OF CANCER SCREENING AMONG GEORGIAN PRIMARY CARE PHYSICIANS.
    Georgian Med News. 2022;:53-58.
    PubMed    
    Abstract available

  105. TOGAMI S, Fukuda M, Yanazume S, Kamio M, et al
    A preliminary study on the detection of lymph node metastasis in cervical cancer using a quantitative RT-PCR assay.
    Jpn J Clin Oncol. 2022 Feb 3. pii: 6520707. doi: 10.1093.
    PubMed    
    Abstract available

  106. KUSMITA L, Franyoto YD, Mutmainah M, Puspitaningrum I, et al
    Bixa orellana L. carotenoids: antiproliferative activity on human lung cancer, breast cancer, and cervical cancer cells in vitro.
    Nat Prod Res. 2022 Feb 8:1-7. doi: 10.1080/14786419.2022.2036144.
    PubMed    
    Abstract available

  107. MA HM, Zhang Q, Yang XM, Hu Y, et al
    HNF4A Regulates the Proliferation and Tumor Formation of Cervical Cancer Cells through the Wnt/beta-Catenin Pathway.
    Oxid Med Cell Longev. 2022;2022:8168988.
    PubMed    
    Abstract available

  108. VOLESKY KD, Magnan S, Mayrand MH, Isidean SD, et al
    Clinical performance of the BD Onclarity extended genotyping assay for the management of women positive for human papillomavirus in cervical cancer screening.
    Cancer Epidemiol Biomarkers Prev. 2022 Feb 7. pii: 1055-9965.EPI-21-1082.
    PubMed    
    Abstract available

  109. LEVKOVICH I, Hamama-Raz Y, Shinan-Altman S
    "A kaleidoscope of relationships" - cervical cancer survivors' perspectives on their intimate relationships: A qualitative study.
    Palliat Support Care. 2022 Feb 8:1-10. doi: 10.1017/S147895152100198.
    PubMed    
    Abstract available

  110. ZHANG Y, Li N, Yuan G, Yao H, et al
    Upregulation of NOD1 and NOD2 contribute to cancer progression through the positive regulation of tumorigenicity and metastasis in human squamous cervical cancer.
    BMC Med. 2022;20:55.
    PubMed    
    Abstract available

  111. REYNOLDS EE, Weinstein A, Farid H, Libman H, et al
    When and How Would You Screen This Patient for Cervical Cancer? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Ann Intern Med. 2022 Feb 8. doi: 10.7326/M21-4372.
    PubMed    
    Abstract available

  112. KISU I, Iida M, Shiraishi T, Banno K, et al
    Novel vaginoplasty technique involving the use of peritoneal flaps during laparoscopic radical hysterectomy for early-stage cervical cancer.
    J Gynecol Oncol. 2022 Jan 10. pii: 33.e19. doi: 10.3802/jgo.2022.
    PubMed    
    Abstract available

  113. DAMIAN FB, de Almeida FK, Fernandes FS, Jimenez MF, et al
    Impact of hydronephrosis and kidney function on survival in newly diagnosed advanced cervical cancer.
    Gynecol Oncol Rep. 2022;39:100934.
    PubMed    
    Abstract available

  114. LEE J, Lin JB, Chen TC, Jan YT, et al
    Progressive Skeletal Muscle Loss After Surgery and Adjuvant Radiotherapy Impact Survival Outcomes in Patients With Early Stage Cervical Cancer.
    Front Nutr. 2022;8:773506.
    PubMed    
    Abstract available

  115. ZHU HT, Yan WJ, Gao YH
    The Clinical Aspects and Prognostic Factors Concerning Survival in Patients With Recurrent Cervical Cancer After Radical Hysterectomy and Adjuvant Chemoradiotherapy.
    Front Oncol. 2022;11:782403.
    PubMed    
    Abstract available

  116. O'DONOVAN B, Mooney T, Rimmer B, Fitzpatrick P, et al
    Trust and cancer screening: Effects of a screening controversy on women's perceptions of cervical cancer screening.
    Prev Med Rep. 2021;25:101684.
    PubMed    
    Abstract available

  117. LONG X, Zheng M, Yang Y, Chen Y, et al
    circ_ZFR Is Linked to Paclitaxel Resistance in Cervical Cancer via miR-944 Sponging and IL-10 Upregulation.
    Anal Cell Pathol (Amst). 2022;2022:4807287.
    PubMed    
    Abstract available

  118. CHAI Y, Wang L, Qu Y, Hu Z, et al
    LncRNA MAGI2-As3 Suppresses the Proliferation and Invasion of Cervical Cancer by Sponging MiR-15b.
    J Healthc Eng. 2022;2022:9707206.
    PubMed    
    Abstract available

  119. JIANG Y, Chen S
    Functional New Transcription Factors (TFs) Associated with Cervical Cancer.
    J Healthc Eng. 2022;2022:8381559.
    PubMed    
    Abstract available

  120. BOURAOUI I, Bouaziz H, Tounsi N, Ben Romdhane R, et al
    Survival After Pelvic Exenteration for Cervical Cancer.
    J Obstet Gynaecol India. 2022;72:66-71.
    PubMed    
    Abstract available

  121. LUCKSOM PG, Sherpa ML, Pradhan A, Lal S, et al
    Advances in HPV Screening Tests for Cervical Cancer-A Review.
    J Obstet Gynaecol India. 2022;72:13-18.
    PubMed    
    Abstract available

  122. NISSIM O, Dees A, Cooper SL, Patel K, et al
    Cervical Cancer Among Women With HIV in South Carolina During the Era of Effective Antiretroviral Therapy.
    J Low Genit Tract Dis. 2022 Feb 3. pii: 00128360-900000000-99318.
    PubMed    
    Abstract available

  123. CUI S, Chen T, Wang M, Chen Y, et al
    Tanshinone I inhibits metastasis of cervical cancer cells by inducing BNIP3/NIX-mediated mitophagy and reprogramming mitochondrial metabolism.
    Phytomedicine. 2022;98:153958.
    PubMed    
    Abstract available

  124. SINGHAL S, Veeratterapillay J, Locks S, Morgan D, et al
    Magnetic Resonance Imaging-Guided Adaptive Brachytherapy for the Treatment of Cervical Cancer and its Impact on Clinical Outcome.
    Clin Oncol (R Coll Radiol). 2022 Feb 2. pii: S0936-6555(22)00059.
    PubMed    
    Abstract available

  125. TAN J, Yang L, Zhao H, Ai Y, et al
    The role of NFATc1/c-myc/PKM2/IL-10 axis in activating cervical cancer tumor-associated M2 macrophage polarization to promote cervical cancer progression.
    Exp Cell Res. 2022 Feb 2:113052. doi: 10.1016/j.yexcr.2022.113052.
    PubMed    
    Abstract available

  126. CHAN DNS, So WKW
    Influential barriers perceived by South Asians in Hong Kong to undergoing cervical cancer screening.
    Eur J Cancer Care (Engl). 2022 Feb 5:e13556. doi: 10.1111/ecc.13556.
    PubMed    
    Abstract available

  127. GINSBURG O, Basu P, Kapambwe S, Canfell K, et al
    Eliminating cervical cancer in the COVID-19 era.
    Nat Cancer. 2021;2:133-134.
    PubMed    


  128. LEWIS-THAMES MW, Tom LS, Leung IS, Yang A, et al
    An examination of the implementation of a patient navigation program to improve breast and cervical cancer screening rates of Chinese immigrant women: a qualitative study.
    BMC Womens Health. 2022;22:28.
    PubMed    
    Abstract available

  129. WANG LN, Wang L, Cheng G, Dai M, et al
    The association of telomere maintenance and TERT expression with susceptibility to human papillomavirus infection in cervical epithelium.
    Cell Mol Life Sci. 2022;79:110.
    PubMed    
    Abstract available

  130. SI M, Su X, Jiang Y, Wang W, et al
    Effect of an IMB Model-Based Education on the Acceptability of HPV Vaccination Among College Girls in Mainland China: A Cluster RCT.
    Cancer Control. 2022;29:10732748211070719.
    PubMed    
    Abstract available

  131. CHEN Y, Zhang H, Zhou Q, Lu L, et al
    Metastases to duodenum in cervical squamous cell carcinoma: A case report and review of the literature.
    Medicine (Baltimore). 2022;101:e28526.
    PubMed    
    Abstract available

  132. OVESTAD IT, Engesaeter B, Halle MK, Akbari S, et al
    High-Grade Cervical Intraepithelial Neoplasia (CIN) Associates with Increased Proliferation and Attenuated Immune Signaling.
    Int J Mol Sci. 2021;23.
    PubMed    
    Abstract available

  133. PU G, Jiang S, Yang Z, Hu Y, et al
    Deep reinforcement learning for treatment planning in high-dose-rate cervical brachytherapy.
    Phys Med. 2022;94:1-7.
    PubMed    
    Abstract available

  134. HU J, Li X, Fang Y, Peng J, et al
    Efficacy and safety of Buzhong Yiqi Decoction in improving cancer-related fatigue and immunity of cervical carcinoma patients: A protocol of randomized controlled trial.
    Medicine (Baltimore). 2021;100:e27938.
    PubMed    
    Abstract available

  135. MIKI M, Imaeda Y, Takahashi H, Iwata A, et al
    Lower accuracy of cytological screening for high-grade squamous intraepithelial neoplasia in women over 50 years of age in Japan.
    Int J Clin Oncol. 2022;27:427-433.
    PubMed    
    Abstract available

  136. DANKAI W, Khunamornpong S, Siriaunkgul S, Soongkhaw A, et al
    An Evaluation of Phosphate Buffer Saline as an Alternative Liquid-Based Medium for HPV DNA Detection.
    Asian Pac J Cancer Prev. 2021;22:3441-3445.
    PubMed    
    Abstract available

  137. PARSAEIAN SF, Asadian F, Karimi-Zarchi M, Setayesh S, et al
    A Meta-Analysis for Association of XRCC3 rs861539, MTHFR rs1801133, IL-6 rs1800795, IL-12B rs3212227, TNF-alpha rs1800629, and TLR9 rs352140 Polymorphisms with Susceptibility to Cervical Carcinoma.
    Asian Pac J Cancer Prev. 2021;22:3419-3431.
    PubMed    
    Abstract available

  138. GAO P, Chen S, Liu S, Liu H, et al
    Chiral Carbon Dots-Enzyme Nanoreactors with Enhanced Catalytic Activity for Cancer Therapy.
    ACS Appl Mater Interfaces. 2021;13:56456-56464.
    PubMed    
    Abstract available

  139. NIU J, Pan S, Wei Y, Hong Z, et al
    Epidemiology and analysis of potential risk factors of high-risk human papillomavirus (HPV) in Shanghai China: A cross-sectional one-year study in non-vaccinated women.
    J Med Virol. 2022;94:761-770.
    PubMed    
    Abstract available

  140. GOSWAMI A, Bhuniya U, Chatterjee S, Mandal P, et al
    The influence of IL1RN VNTR polymorphism on HPV infection among some tribal communities.
    J Med Virol. 2022;94:752-760.
    PubMed    
    Abstract available

  141. VATTAI A, Kremer N, Meister S, Beyer S, et al
    Role of FoxP3-positive regulatory T-cells in regressive and progressive cervical dysplasia.
    J Cancer Res Clin Oncol. 2022;148:377-386.
    PubMed    
    Abstract available

  142. XU Y, Harris T, O'Farrell D, Cormack R, et al
    Interfraction dose deviation and catheter position in cervical interstitial and intracavitary image guided HDR brachytherapy.
    Med Dosim. 2022;47:e1-e6.
    PubMed    
    Abstract available

  143. HUSSAIN SS, Lundine D, Leeman JE, Higginson DS, et al
    Genomic Signatures in HPV-Associated Tumors.
    Viruses. 2021;13.
    PubMed    
    Abstract available

  144. PINHEIRO M, Harari A, Schiffman M, Clifford GM, et al
    Phylogenomic Analysis of Human Papillomavirus Type 31 and Cervical Carcinogenesis: A Study of 2093 Viral Genomes.
    Viruses. 2021;13.
    PubMed    
    Abstract available

  145. NADOVA K, Burghardtova M, Fejfarova K, Reginacova K, et al
    Late Radiation-Related Toxicities in Patients Treated for Early-Stage Cervical Carcinoma by Surgery and Adjuvant Radiotherapy: A Retrospective Imaging Study.
    Pathol Oncol Res. 2021;27:1609915.
    PubMed    
    Abstract available

  146. TOTARO ME, Gili JA, Liotta DJ, Schurr TG, et al
    Genetic variation in the E6 and E7 genes of human papillomavirus type 16 in northeastern Argentina.
    J Med Virol. 2022;94:745-751.
    PubMed    
    Abstract available

  147. ADAMOPOULOU M, Avgoustidis D, Voyiatjaki C, Beloukas A, et al
    Impact of combined mycoplasmataceae and HPV co-infection on females with cervical intraepithelial neoplasia and carcinoma.
    J BUON. 2021;26:1313-1319.
    PubMed    
    Abstract available

  148. LIOU S, Nilforoushan N, Kang Y, Moatamed NA, et al
    p16 is superior to Stathmin-1 and HSP27 in identifying cervical dysplasia.
    Diagn Pathol. 2021;16:85.
    PubMed    
    Abstract available

  149. DIAZ-TEJEDA Y, Guido-Jimenez MC, Lopez-Carbajal H, Amador-Molina A, et al
    Nanog, in Cooperation with AP1, Increases the Expression of E6/E7 Oncogenes from HPV Types 16/18.
    Viruses. 2021;13.
    PubMed    
    Abstract available

  150. AKKOUR K, Alhulwah M, Alhalal H, Alqahtani N, et al
    Primary extranodal diffuse large B-cell lymphoma of the uterine cervix.
    Malays J Pathol. 2021;43:327-331.
    PubMed    
    Abstract available

  151. SONG F, Jia M, Yu S, Cao L, et al
    PD-L1 expression and immune stromal features in HPV-independent cervical adenocarcinoma.
    Histopathology. 2021;79:861-871.
    PubMed    
    Abstract available

  152. MA MJ, Wang YN, Zhu JF, Wang XY, et al
    Characterization of HPV subtypes not covered by the nine-valent vaccine in patients with CIN 2-3 and cervical squamous cell carcinoma.
    Curr Probl Cancer. 2021;45:100761.
    PubMed    
    Abstract available

  153. MANTOANI PTS, Jammal MP, Caixeta JM, Cordeiro NA, et al
    Association of lesion area measured by colposcopy and cervical neoplasia.
    J Obstet Gynaecol. 2022;42:306-309.
    PubMed    
    Abstract available

  154. TANG HP, Cai, Kong YQ, Ye H, et al
    Cervical cytology screening facilitated by an artificial intelligence microscope: A preliminary study.
    Cancer Cytopathol. 2021;129:693-700.
    PubMed    
    Abstract available

  155. KANG EY, Tessier-Cloutier B, Duggan MA, Stewart CJR, et al
    Loss of ARID1B and SMARCB1 expression are specific for the diagnosis of dedifferentiated/undifferentiated carcinoma in tumours of the upper gynaecological tract and cervix.
    Histopathology. 2021;79:160-167.
    PubMed    
    Abstract available

  156. SUNDSTROM K, Dillner J
    How Many Human Papillomavirus Types Do We Need to Screen For?
    J Infect Dis. 2021;223:1510-1511.
    PubMed    


  157. KHOO SP, Lim WT, Rajasuriar R, Nasir NH, et al
    The Acceptability and Preference of Vaginal Self-sampling for Human Papillomavirus (HPV) Testing among a Multi-ethnic Asian Female Population.
    Cancer Prev Res (Phila). 2021;14:105-112.
    PubMed    
    Abstract available

  158. TOTA JE, Struyf F, Hildesheim A, Gonzalez P, et al
    Efficacy of AS04-adjuvanted HPV-16/18 vaccine against clearance of incident HPV infections: Pooled analysis of data from the CVT and PATRICIA randomized trials.
    J Infect Dis. 2020 Sep 5. pii: 5901687. doi: 10.1093.
    PubMed    
    Abstract available

  159. GUO F, Liu Y, Cheng Y, Zhang Q, et al
    Transcriptome analysis reveals the potential biological function of FSCN1 in HeLa cervical cancer cells.
    PeerJ. 2022;10:e12909.
    PubMed    
    Abstract available

  160. HAYUMBU V, Hangoma J, Hamooya BM, Malumani M, et al
    Cervical cancer and precancerous cervical lesions detected using visual inspection with acetic acid at Livingstone Teaching Hospital.
    Pan Afr Med J. 2021;40:235.
    PubMed    
    Abstract available

  161. JIANG Z, Li J, Feng W, Sun Y, et al
    A Ferroptosis-Related lncRNA Model to Enhance the Predicted Value of Cervical Cancer.
    J Oncol. 2022;2022:6080049.
    PubMed    
    Abstract available

  162. ZELLI J, Hum S, Lofters A, Dunn S, et al
    Clinician acceptability of self-collected human papillomavirus swabs as a primary cervical cancer screening method.
    Can Fam Physician. 2022;68:e31-e38.
    PubMed    
    Abstract available

  163. DOLEEB Z, Tesfaye M, Selk A, Dunn S, et al
    The pandemic and cervical cancer screening: Is it finally time to adopt HPV self-swabbing tests in Canada?
    Can Fam Physician. 2022;68:90-92.
    PubMed    


  164. GUO J, Luo N, Ai G, Yang W, et al
    Eradicating tumor in a recurrent cervical cancer patient with autologous tumor-infiltrating lymphocytes and a modified lymphodepleting regimen.
    J Immunother Cancer. 2022;10.
    PubMed    
    Abstract available

  165. HUEPENBECKER SP, Meyer LA
    How Can We Pursue Equity in Cervical Cancer Prevention with Existing HPV Genotype Differences?
    J Natl Cancer Inst. 2022 Feb 17. pii: 6530293. doi: 10.1093.
    PubMed    


  166. CHEN J, Bai H
    Evaluation of Implementation Effect of Cervical Cancer Comprehensive Treatment Patients With Whole-Course High-Quality Care Combined With Network Continuation Care.
    Front Surg. 2022;9:838848.
    PubMed    
    Abstract available

  167. LIU H, Zhou S, Liu J, Chen F, et al
    Lirilumab and Avelumab Enhance Anti-HPV+ Cervical Cancer Activity of Natural Killer Cells via Vav1-Dependent NF-kappaB Disinhibition.
    Front Oncol. 2022;12:747482.
    PubMed    
    Abstract available

  168. ZHANG L, Wang J, Chen T, Tian M, et al
    Symptom Clusters and Quality of Life in Cervical Cancer Patients Receiving Concurrent Chemoradiotherapy: The Mediating Role of Illness Perceptions.
    Front Psychiatry. 2022;12:807974.
    PubMed    
    Abstract available


  169. Procyanidin Compound (PC) Suppresses Lipopolysaccharide-Induced Cervical Cancer Cell Proliferation Through Blocking the TLR4/NF-kappaB Pathway [Retraction].
    Cancer Manag Res. 2022;14:449-450.
    PubMed    
    Abstract available


  170. Correction: Genomic profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: a secondary analysis of the CLAP trial.
    J Immunother Cancer. 2022;10.
    PubMed    


  171. FU Y, Li X, Li Y, Lu W, et al
    Head-to-Head Comparison of DH3 HPV Test and HC2 Assay for Detection of High-Risk HPV Infection in Residual Cytology Samples from Cervical Cancer Screening Setting: Baseline and 3-Year Longitudinal Data.
    Microbiol Spectr. 2022 Feb 16:e0157021. doi: 10.1128/spectrum.01570.
    PubMed    
    Abstract available

  172. CARVALHO CF, Teixeira JC, Braganca JF, Derchain S, et al
    Cervical Cancer Screening with HPV Testing: Updates on the Recommendation.
    Rev Bras Ginecol Obstet. 2022 Feb 15. doi: 10.1055/s-0041-1739314.
    PubMed    
    Abstract available

  173. KARASAWA Y, Mabuchi S, Matsumoto Y, Umemoto M, et al
    Iliac artery-enteric fistula developed during bevacizumab-containing chemotherapy for recurrent cervical cancer: A case report and literature review.
    Gynecol Oncol Rep. 2022;40:100938.
    PubMed    
    Abstract available

  174. SINGH V, Gor D, Azad S, Ricca A, et al
    Dysphagia as a Rare Presentation of Cervical Cancer with Mediastinal Metastasis.
    Eur J Case Rep Intern Med. 2022;9:003136.
    PubMed    
    Abstract available

  175. BECKMANN MW, Stubs FA, Koch MC, Mallmann P, et al
    Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy.
    Geburtshilfe Frauenheilkd. 2022;82:139-180.
    PubMed    
    Abstract available

  176. XUE P, Wang J, Qin D, Yan H, et al
    Deep learning in image-based breast and cervical cancer detection: a systematic review and meta-analysis.
    NPJ Digit Med. 2022;5:19.
    PubMed    
    Abstract available

  177. CHEN R, Liang F, Yan J, Wang Y, et al
    CircCDK17 knockdown inhibits tumor progression and cell glycolysis by downregulaing YWHAZ expression through sponging miR-1294 in cervical cancer.
    J Ovarian Res. 2022;15:24.
    PubMed    
    Abstract available

  178. ZHANG X, Sun Y, Cheng S, Yao Y, et al
    CDK6 increases glycolysis and suppresses autophagy by mTORC1-HK2 pathway activation in cervical cancer cells.
    Cell Cycle. 2022 Feb 15:1-19. doi: 10.1080/15384101.2022.2039981.
    PubMed    
    Abstract available

  179. BRANDT B, Levin G, Leitao MM Jr
    Radical Hysterectomy for Cervical Cancer: the Right Surgical Approach.
    Curr Treat Options Oncol. 2022 Feb 15. pii: 10.1007/s11864-021-00919.
    PubMed    
    Abstract available

  180. MILLET N, Moss EL, Munir F, Rogers E, et al
    A qualitative exploration of physical and psychosocial well-being in the short and long term after treatments for cervical cancer.
    Eur J Cancer Care (Engl). 2022 Feb 15:e13560. doi: 10.1111/ecc.13560.
    PubMed    
    Abstract available

  181. GAMELIN R, Hebert M, Tratt E, Brassard P, et al
    Ethnographic study of the barriers and facilitators to implementing human papillomavirus (HPV) self-sampling as a primary screening strategy for cervical cancer among Inuit women of Nunavik, Northern Quebec.
    Int J Circumpolar Health. 2022;81:2032930.
    PubMed    
    Abstract available

  182. ZHANG S, Xu Y, Zheng Q
    circRNA_0000285 knockdown suppresses viability and promotes apoptosis of cervical cancer cells by sponging microRNA-654-3p.
    Bioengineered. 2022;13:5251-5261.
    PubMed    
    Abstract available

  183. GERSTL S, Lee L, Nesbitt RC, Mambula C, et al
    Cervical cancer screening coverage and its related knowledge in southern Malawi.
    BMC Public Health. 2022;22:295.
    PubMed    
    Abstract available

  184. ZAHID HM, Qarah AB, Alharbi AM, Alomar AE, et al
    Awareness and Practices Related to Cervical Cancer among Females in Saudi Arabia.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  185. NGUYEN VT, Winterman S, Playe M, Benbara A, et al
    Dose-Intense Cisplatin-Based Neoadjuvant Chemotherapy Increases Survival in Advanced Cervical Cancer: An Up-to-Date Meta-Analysis.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  186. BUDA A, Borghese M, Puppo A, Perotto S, et al
    Neoadjuvant Chemotherapy Prior Fertility-Sparing Surgery in Women with FIGO 2018 Stage IB2 Cervical Cancer: A Systematic Review.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  187. FERNANDEZ-GONZALEZ S, Ponce J, Martinez-Maestre MA, Barahona M, et al
    The Impact of Surgical Practice on Oncological Outcomes in Robot-Assisted Radical Hysterectomy for Early-Stage Cervical Cancer, Spanish National Registry.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  188. MINNAAR CA, Maposa I, Kotzen JA, Baeyens A, et al
    Effects of Modulated Electro-Hyperthermia (mEHT) on Two and Three Year Survival of Locally Advanced Cervical Cancer Patients.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  189. GUIMARAES YM, Godoy LR, Longatto-Filho A, Reis RD, et al
    Management of Early-Stage Cervical Cancer: A Literature Review.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  190. MOURA EL, Santos IFD, Freitas PP, Silva DMD, et al
    Polymorphisms in Toll-like receptors genes changes the host's immune response and is associated with cervical cancer.
    Immunobiology. 2022;227:152187.
    PubMed    
    Abstract available

  191. YUAN Z, Wang Y, Hu P, Zhang D, et al
    Accelerate treatment planning process using deep learning generated fluence maps for cervical cancer radiation therapy.
    Med Phys. 2022 Feb 14. doi: 10.1002/mp.15530.
    PubMed    
    Abstract available

  192. RAMACHANDRAN D, Dennis J, Fachal L, Schurmann P, et al
    Genome-wide association study and functional follow-up identifies 14q12 as a candidate risk locus for cervical cancer.
    Hum Mol Genet. 2022 Feb 14. pii: 6528272. doi: 10.1093.
    PubMed    
    Abstract available

  193. HE F, Yuan S, Chen X, Zhang S, et al
    Effect of modified no-touch laparoscopic radical hysterectomy on outcomes of early stage cervical cancer: A retrospective cohort study.
    Cancer Med. 2022 Feb 13. doi: 10.1002/cam4.4612.
    PubMed    
    Abstract available

  194. SUN S, Chen Z, Li P, Wu J, et al
    Clinical study of acute toxicity of pelvic bone marrow-sparing intensity-modulated radiotherapy for cervical cancer.
    Ginekol Pol. 2022 Feb 14. pii: VM/OJS/J/72864. doi: 10.5603/GP.a2021.0234.
    PubMed    
    Abstract available

  195. EDWARDS K, Fatehi M, Fogel J
    Post-Menopausal Status and Risk for Cervical Dysplasia.
    Gulf J Oncolog. 2022;1:31-37.
    PubMed    
    Abstract available

  196. SINNATAMBY M, Kandasamy S, Karunanidhi G, Neelakandan V, et al
    Image-Guided Brachytherapy a Comparison Between 192Ir and 60Co Sources in Carcinoma Uterine Cervix.
    Gulf J Oncolog. 2022;1:7-14.
    PubMed    
    Abstract available

  197. ZHANG H, Wang R, Tang X, Li J, et al
    FASN Targeted by miR-497-5p Regulates Cell Behaviors in Cervical Cancer.
    Nutr Cancer. 2022 Feb 14:1-10. doi: 10.1080/01635581.2022.2036351.
    PubMed    
    Abstract available

  198. BAO H, Zhang X, Bi H, Zhao Y, et al
    How Can a High-Performance Screening Strategy Be Determined for Cervical Cancer Prevention? Evidence From a Hierarchical Clustering Analysis of a Multicentric Clinical Study.
    Front Oncol. 2022;12:816789.
    PubMed    
    Abstract available

  199. HILGERS K, Ibrahim SA, Kiesel L, Greve B, et al
    Differential Impact of Membrane-Bound and Soluble Forms of the Prognostic Marker Syndecan-1 on the Invasiveness, Migration, Apoptosis, and Proliferation of Cervical Cancer Cells.
    Front Oncol. 2022;12:803899.
    PubMed    
    Abstract available

  200. WANG YM, Qiu JJ, Qu XY, Peng J, et al
    Accumulation of dysfunctional tumor-infiltrating PD-1+ DCs links PD-1/PD-L1 blockade immunotherapeutic response in cervical cancer.
    Oncoimmunology. 2022;11:2034257.
    PubMed    
    Abstract available

  201. PERIASAMY VS, Athinarayanan J, Ramankutty G, Akbarsha MA, et al
    Plumbagin triggers redox-mediated autophagy through the LC3B protein in human papillomavirus-positive cervical cancer cells.
    Arch Med Sci. 2020;18:171-182.
    PubMed    
    Abstract available

  202. ZHENG Q, Lin C, Xu D, Zhao H, et al
    A Preliminary Study on Exploring a potential Ultrasound Method for Predicting Cervical Cancer.
    J Cancer. 2022;13:793-799.
    PubMed    
    Abstract available

  203. GASIMLI K, Raab M, Becker S, Sanhaji M, et al
    The Role of DAPK1 in the Cell Cycle Regulation of Cervical Cancer Cells and in Response to Topotecan.
    J Cancer. 2022;13:728-743.
    PubMed    
    Abstract available

  204. AN R, Meng S, Qian H
    Identification of Key Pathways and Establishment of a Seven-Gene Prognostic Signature in Cervical Cancer.
    J Oncol. 2022;2022:4748796.
    PubMed    
    Abstract available

  205. YANG J, Wu Z, Yang L, Jeong JH, et al
    Characterization of Kinesin Family Member 2C as a Proto-Oncogene in Cervical Cancer.
    Front Pharmacol. 2022;12:785981.
    PubMed    
    Abstract available

  206. ZHONG P, Guo A, Wang L, Lin X, et al
    Circular RNA CDK6 suppresses cervical cancer proliferation and metastasis by sponging miR-449a.
    Bioengineered. 2022;13:4885-4897.
    PubMed    
    Abstract available

  207. ZHAO LH, Ma Q, Fu P, Mao CY, et al
    [Clinicopathological analysis of invasive stratified mucin-producing carcinoma of the uterine cervix].
    Zhonghua Bing Li Xue Za Zhi. 2022;51:135-137.
    PubMed    


  208. LIAO Y, Huang J, Liu P, Zhang C, et al
    Downregulation of LNMAS orchestrates partial EMT and immune escape from macrophage phagocytosis to promote lymph node metastasis of cervical cancer.
    Oncogene. 2022 Feb 12. pii: 10.1038/s41388-022-02202.
    PubMed    
    Abstract available

  209. ZHU Y, Ren C, Yang L, Zhang Z, et al
    Correction to: Identification and validation of the high expression of pseudogene TCAM1P in cervical cancer via integrated bioinformatics analysis.
    Cancer Cell Int. 2022;22:77.
    PubMed    


  210. MENG X, Cui X, Shao X, Liu Y, et al
    poly(I:C) synergizes with proteasome inhibitors to induce apoptosis in cervical cancer cells.
    Transl Oncol. 2022;18:101362.
    PubMed    
    Abstract available

  211. ZHANG J, Yu G, Yang Y, Wang Y, et al
    A small-molecule inhibitor of MDMX suppresses cervical cancer cells via the inhibition of E6-E6AP-p53 axis.
    Pharmacol Res. 2022;177:106128.
    PubMed    
    Abstract available

  212. GINJUPALLI R, Mundaden R, Choi Y, Herfel E, et al
    Developing a framework to describe stigma related to cervical cancer and HPV in western Kenya.
    BMC Womens Health. 2022;22:39.
    PubMed    
    Abstract available

  213. THUMBOVORN R, Bhattarakosol P, Chaiwongkot A
    Detection of Global DNA Methylation in Cervical Intraepithelial Neoplasia and Cancerous Lesions by Pyrosequencing and Enzyme-Linked Immunosorbent Assays.
    Asian Pac J Cancer Prev. 2022;23:143-149.
    PubMed    
    Abstract available

  214. FLORIDIA M, Masuelli G, Tassis B, Savasi VM, et al
    Minimal prevalence of HPV vaccination and common occurrence of high-risk HPV types in pregnant women with HIV: data from a national study in Italy.
    Eur J Clin Microbiol Infect Dis. 2022 Jan 9. pii: 10.1007/s10096-021-04393.
    PubMed    
    Abstract available

  215. SASIENI P
    Alternative analysis of the data from a HPV vaccine study in India.
    Lancet Oncol. 2022;23:e9.
    PubMed    


  216. BASU P, Muwonge R
    Alternative analysis of the data from a HPV vaccine study in India - Authors' reply.
    Lancet Oncol. 2022;23:e10.
    PubMed    


  217. LIU L, Chen X, Li J, Wang H, et al
    Autophosphorylation transforms DNA-PK from protecting to processing DNA ends.
    Mol Cell. 2022;82:177-189.
    PubMed    
    Abstract available

  218. ZHANG XQ, Li L
    A meta-analysis of XRCC1 single nucleotide polymorphism and susceptibility to gynecological malignancies.
    Medicine (Baltimore). 2021;100:e28030.
    PubMed    
    Abstract available

  219. SKRET A, Trawinska J, Bielatowicz J, Ksiazek M, et al
    Synchronous occurrence of HPV-associated cervical squamous cell carcinoma (FIGO IIA) in prolapsed uterus and adenocarcinoma of the anal canal cT1N0M0: Case report.
    Medicine (Baltimore). 2021;100:e28004.
    PubMed    
    Abstract available

  220. ZHENG Z, Yang X, Yao X, Li L, et al
    Prognostic value of HPV 16/18 genotyping and geminin mRNA quantification in low-grade cervical squamous intraepithelial lesion.
    Bioengineered. 2021;12:11482-11489.
    PubMed    
    Abstract available

  221. HUANG J, Luo F, Shi M, Luo J, et al
    Construction and validation of a metabolic gene-associated prognostic model for cervical carcinoma and the role on tumor microenvironment and immunity.
    Aging (Albany NY). 2021;13:25072-25088.
    PubMed    
    Abstract available

  222. SENA MM, Trugilo KP, Okuyama NCM, Pereira ER, et al
    The role of NFKB1/NFKBIA genetic variants in HPV infection: A cross-sectional cohort study.
    Exp Mol Pathol. 2022;124:104716.
    PubMed    
    Abstract available

  223. LAU HW, Ma HT, Yeung TK, Tam MY, et al
    Quantitative differences between cyclin-dependent kinases underlie the unique functions of CDK1 in human cells.
    Cell Rep. 2021;37:109808.
    PubMed    
    Abstract available

  224. SYKES PH, Simcock BJ, Innes CR, Harker D, et al
    Predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years.
    Am J Obstet Gynecol. 2022;226:222.
    PubMed    
    Abstract available

  225. NIN DS, Wujanto C, Tan TZ, Lim D, et al
    GAGE mediates radio resistance in cervical cancers via the regulation of chromatin accessibility.
    Cell Rep. 2021;36:109621.
    PubMed    
    Abstract available

  226. ABE A, Yuasa M, Imai Y, Kagawa T, et al
    Extreme leanness, lower skeletal muscle quality, and loss of muscle mass during treatment are predictors of poor prognosis in cervical cancer treated with concurrent chemoradiation therapy.
    Int J Clin Oncol. 2022 Feb 25. pii: 10.1007/s10147-022-02140.
    PubMed    
    Abstract available

  227. YANG EJ, Kim NR, Lee AJ, Shim SH, et al
    Laparotomic radical hysterectomy versus minimally invasive radical hysterectomy using vaginal colpotomy for the management of stage IB1 to IIA2 cervical cancer: Survival outcomes.
    Medicine (Baltimore). 2022;101:e28911.
    PubMed    
    Abstract available


  228. Retraction: LncRNA LIPE-AS1 Predicts Poor Survival of Cervical Cancer and Promotes Its Proliferation and Migration via Modulating miR-195-5p/MAPK Pathway.
    Front Oncol. 2022;12:858846.
    PubMed    
    Abstract available

  229. SONG C, Lee Y, Kim S
    Bioinformatic Analysis for the Prognostic Implication of Genes Encoding Epithelial Sodium Channel in Cervical Cancer.
    Int J Gen Med. 2022;15:1777-1787.
    PubMed    
    Abstract available

  230. UTAMA K, Khamto N, Meepowpan P, Aobchey P, et al
    Effects of 2',4'-Dihydroxy-6'-methoxy-3',5'-dimethylchalcone from Syzygium nervosum Seeds on Antiproliferative, DNA Damage, Cell Cycle Arrest, and Apoptosis in Human Cervical Cancer Cell Lines.
    Molecules. 2022;27.
    PubMed    
    Abstract available

  231. SAMI J, Lemoupa Makajio S, Jeannot E, Kenfack B, et al
    Smartphone-Based Visual Inspection with Acetic Acid: An Innovative Tool to Improve Cervical Cancer Screening in Low-Resource Setting.
    Healthcare (Basel). 2022;10.
    PubMed    
    Abstract available

  232. QIU L, Feng H, Yu H, Li M, et al
    Characterization of the Genomic Landscape in Cervical Cancer by Next Generation Sequencing.
    Genes (Basel). 2022;13.
    PubMed    
    Abstract available

  233. SANNA E, Chiappe G, Lavra F, Nemolato S, et al
    Diagnostic Framework of Pelvic Massive Necrosis with Peritonitis following Chemoradiation for Locally Advanced Cervical Cancer: When Is the Surgery Not Demandable? A Case Report and Literature Review.
    Diagnostics (Basel). 2022;12.
    PubMed    
    Abstract available

  234. LI C, Zhang L, Liu C, He X, et al
    Lipophilic Grape Seed Proanthocyanidin Exerts Anti-Cervical Cancer Effects in HeLa Cells and a HeLa-Derived Xenograft Zebrafish Model.
    Antioxidants (Basel). 2022;11.
    PubMed    
    Abstract available

  235. SHARMA M, Batra K, Johansen C, Raich S, et al
    Explaining Correlates of Cervical Cancer Screening among Minority Women in the United States.
    Pharmacy (Basel). 2022;10.
    PubMed    
    Abstract available

  236. RAMEZANI FARANI M, Azarian M, Heydari Sheikh Hossein H, Abdolvahabi Z, et al
    Folic Acid-Adorned Curcumin-Loaded Iron Oxide Nanoparticles for Cervical Cancer.
    ACS Appl Bio Mater. 2022 Feb 24. doi: 10.1021/acsabm.1c01311.
    PubMed    
    Abstract available

  237. XU Y, Liu Y, Huang W, Yang C, et al
    LOC100130075 Promotes Cervical Cancer Progression by Activating MDM2 Transcription through E2F1.
    Reprod Sci. 2022 Feb 24. pii: 10.1007/s43032-021-00806.
    PubMed    
    Abstract available

  238. CAIRD H, Simkin J, Smith L, Van Niekerk D, et al
    The Path to Eliminating Cervical Cancer in Canada: Past, Present and Future Directions.
    Curr Oncol. 2022;29:1117-1122.
    PubMed    
    Abstract available

  239. TOUHAMI O, Plante M
    Minimally Invasive Surgery for Cervical Cancer in Light of the LACC Trial: What Have We Learned?
    Curr Oncol. 2022;29:1093-1106.
    PubMed    
    Abstract available

  240. FAYE MD, Alfieri J
    Advances in Radiation Oncology for the Treatment of Cervical Cancer.
    Curr Oncol. 2022;29:928-944.
    PubMed    
    Abstract available

  241. LE D, Coriolan Ciceron A, Jeon MJ, Gonzalez LI, et al
    Cervical Cancer Prevention and High-Risk HPV Self-Sampling Awareness and Acceptability among Women Living with HIV: A Qualitative Investigation from the Patients' and Providers' Perspectives.
    Curr Oncol. 2022;29:516-533.
    PubMed    
    Abstract available

  242. STOCKS J, Choi Y, Ibrahim S, Huchko M, et al
    Iterative Development of a Mobile Phone App to Support Community Health Volunteers During Cervical Cancer Screening in Western Kenya: Qualitative Study.
    JMIR Form Res. 2022;6:e27501.
    PubMed    
    Abstract available

  243. SHRESTHA J, Gharti Magar D, Pandey C
    Cervical Intraepithelial Lesions in Women with Persistent Inflammatory Smear on Pap Smear: A Descriptive Cross-sectional Study.
    JNMA J Nepal Med Assoc. 2021;59:848-852.
    PubMed    
    Abstract available

  244. FEHM T, Stubs FA, Koch MC, Mallmann P, et al
    Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and H
    Geburtshilfe Frauenheilkd. 2022;82:181-205.
    PubMed    
    Abstract available

  245. NYANCHOKA L, Damian A, Nygard M
    Understanding facilitators and barriers to follow-up after abnormal cervical cancer screening examination among women living in remote areas of Romania: a qualitative study protocol.
    BMJ Open. 2022;12:e053954.
    PubMed    
    Abstract available

  246. YOO JG, Kim SI, Yeo SG, Park DC, et al
    Usefulness of Short-Term Imaging and Squamous Cell Carcinoma Antigen to Early Predict Response to Concurrent Chemoradiotherapy in Patients With Cervical Cancer.
    Cancer Control. 2022;29:10732748221074530.
    PubMed    
    Abstract available

  247. OLADERU OT, Ma SJ, Miccio JA, Wang K, et al
    Breast and Cervical Cancer Screening Disparities in Transgender People.
    Am J Clin Oncol. 2022;45:116-121.
    PubMed    
    Abstract available

  248. YUAN N, Wang L, Xi Q, Zou N, et al
    ITGA7, CD133, ALDH1 are inter-correlated, and linked with poor differentiation, lymph node metastasis as well as worse survival in surgical cervical cancer.
    J Obstet Gynaecol Res. 2022 Feb 22. doi: 10.1111/jog.15163.
    PubMed    
    Abstract available

  249. PANG K, Lee J, Kim J, Park J, et al
    Degradation of DRAK1 by CUL3/SPOP E3 Ubiquitin ligase promotes tumor growth of paclitaxel-resistant cervical cancer cells.
    Cell Death Dis. 2022;13:169.
    PubMed    
    Abstract available

  250. XIN H, Pan Z, Zhe X, Zhang C, et al
    HPV16 E6 gene polymorphisms and the functions of the mutation site in cervical cancer among Uygur ethnic and Han nationality women in Xinjiang, China.
    Cancer Cell Int. 2022;22:94.
    PubMed    
    Abstract available

  251. KOU L, Zhang T, Yang X, Peng S, et al
    Role of adjuvant chemotherapy after concurrent chemoradiotherapy in patients with locally advanced cervical cancer.
    Future Oncol. 2022 Feb 23. doi: 10.2217/fon-2021-0818.
    PubMed    
    Abstract available

  252. XU Q, Wang J, Sun Y, Lin Y, et al
    Efficacy and Safety of Sintilimab Plus Anlotinib for PD-L1-Positive Recurrent or Metastatic Cervical Cancer: A Multicenter, Single-Arm, Prospective Phase II Trial.
    J Clin Oncol. 2022 Feb 22:JCO2102091. doi: 10.1200/JCO.21.02091.
    PubMed    
    Abstract available

  253. DING Y, Chen Z, Wang Z, Wang X, et al
    Three-dimensional deep neural network for automatic delineation of cervical cancer in planning computed tomography images.
    J Appl Clin Med Phys. 2022 Feb 22:e13566. doi: 10.1002/acm2.13566.
    PubMed    
    Abstract available

  254. NAKAMURA M, Ito K, Takemura N, Mihara F, et al
    Hepatectomy for liver metastases from cervical cancer with portal vein tumor thrombosis: a case report.
    Clin J Gastroenterol. 2022 Feb 22. pii: 10.1007/s12328-022-01603.
    PubMed    
    Abstract available

  255. TEBEU PM, Ngou-Mve-Ngou JP, Zingue LL, Antaon JSS, et al
    The Pattern of Cervical Cancer according to HIV Status in Yaounde, Cameroon.
    Obstet Gynecol Int. 2021;2021:1999189.
    PubMed    
    Abstract available

  256. F S, Ak Y, C M, S D, et al
    Impact of hematologic toxicities during concurrent chemoradiation for cervical cancer.
    Obstet Gynecol Sci. 2022 Feb 22. pii: ogs.21308. doi: 10.5468/ogs.21308.
    PubMed    
    Abstract available

  257. CHEN R, Yang W, Li Y, Cheng X, et al
    Effect of immunotherapy on the immune microenvironment in advanced recurrent cervical cancer.
    Int Immunopharmacol. 2022;106:108630.
    PubMed    
    Abstract available

  258. ZHANG L, Wang K, Huang Y, Zhang H, et al
    Photosensitizer-induced HPV16 E7 nanovaccines for cervical cancer immunotherapy.
    Biomaterials. 2022;282:121411.
    PubMed    
    Abstract available

  259. HOREWEG N, Mittal P, Gradowska PL, Boere I, et al
    A systematic review and meta-analysis of adjuvant chemotherapy after chemoradiation for locally advanced cervical cancer.
    Crit Rev Oncol Hematol. 2022 Feb 18:103638.
    PubMed    
    Abstract available


  260. Cervical Cancer Screening.
    J Midwifery Womens Health. 2022 Feb 20. doi: 10.1111/jmwh.13347.
    PubMed    


  261. MANZANARES-LEAL GL, Coronel-Martinez JA, Rodriguez-Morales M, Rangel-Cuevas I, et al
    Preliminary Identification of the Aerobic Cervicovaginal Microbiota in Mexican Women With Cervical Cancer as the First Step Towards Metagenomic Studies.
    Front Cell Infect Microbiol. 2022;12:838491.
    PubMed    
    Abstract available

  262. HE S, Wang Y, Lai Y, Cao X, et al
    Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Patients With Stage IIB-IVA Cervical Cancer: A Randomized Phase III Trial.
    Front Oncol. 2022;11:798617.
    PubMed    
    Abstract available

  263. ARCIA FRANCHINI AP, Iskander B, Anwer F, Oliveri F, et al
    The Role of Chlamydia Trachomatis in the Pathogenesis of Cervical Cancer.
    Cureus. 2022;14:e21331.
    PubMed    
    Abstract available

  264. GONG W, Liu Y
    Clinical Effect of Laparoscopic Radical Surgery Combined with Neoadjuvant Chemotherapy in Treating Cervical Cancer and Its Influence on Postoperative Complications and Adverse Reaction Rates.
    J Healthc Eng. 2022;2022:8768188.
    PubMed    
    Abstract available

  265. WEN CX, Tian HL, Chen E, Liu JF, et al
    MiRNA-873-5p Acts as a Potential Novel Biomarker and Promotes Cervical Cancer Progression by Regulating ZEB1 via Notch Signaling Pathway.
    Dose Response. 2021;19:15593258211001255.
    PubMed    
    Abstract available

  266. LI MZ, Wei LH
    [Biology of HPV mediated carcinogenesis and advances of prophylactic means in targeting HPV infection].
    Zhonghua Fu Chan Ke Za Zhi. 2022;57:152-155.
    PubMed    


  267. KUANG L, Zhang B, Sun F, Zhang JB, et al
    [The characteristics of vaginal microbiota and its correlation with cervical cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2022;57:156-160.
    PubMed    


  268. ZHAO S, Zhao XL, Hu SY, Ma JF, et al
    [Performance of point-of-care testing for cervical cancer screening].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2022;56:165-170.
    PubMed    
    Abstract available

  269. RYAN G, Askelson NM, Miotto MB, Goulding M, et al
    Lessons Learned From Human Papillomavirus Vaccination to Increase Uptake of Adolescent COVID-19 Vaccination.
    J Adolesc Health. 2022;70:359-360.
    PubMed    


  270. RAMIREZ-TORRES A, Gil J, Contreras S, Ramirez G, et al
    Quantitative Proteomic Analysis of Cervical Cancer Tissues Identifies Proteins Associated With Cancer Progression.
    Cancer Genomics Proteomics. 2022;19:241-258.
    PubMed    
    Abstract available

  271. GUO Q, Wang R, Jin D, Yin Z, et al
    Comparison of adjuvant chemoradiotherapy versus radiotherapy in early-stage cervical cancer patients with intermediate-risk factors: A systematic review and meta-analysis.
    Taiwan J Obstet Gynecol. 2022;61:15-23.
    PubMed    
    Abstract available

  272. YOUSEFI Z, Aria H, Ghaedrahmati F, Bakhtiari T, et al
    An Update on Human Papilloma Virus Vaccines: History, Types, Protection, and Efficacy.
    Front Immunol. 2022;12:805695.
    PubMed    
    Abstract available

  273. CREAGH NS, Zammit C, Brotherton JM, Saville M, et al
    The experience of under-screened and never-screened participants using clinician-supported self-collection cervical screening within the Australian National Cervical Screening Program.
    Womens Health (Lond). 2022;18:17455065221075905.
    PubMed    
    Abstract available

  274. HARUYAMA R, Obara H, Fujita N
    Japan resumes active recommendations of HPV vaccine after 8.5 years of suspension.
    Lancet Oncol. 2022;23:197-198.
    PubMed    


  275. ZHANG L, Shi X, Zhang Q, Mao Z, et al
    HPV-16 E7-Specific Cellular Immune Response in Women With Cervical Intraepithelial Lesion Contributes to Viral Clearance: A Cross-Sectional and Longitudinal Clinical Study.
    Front Immunol. 2022;12:768144.
    PubMed    
    Abstract available

  276. KAMBLE SA, Dombale VD, Shah F
    Merits and pitfalls of normal saline rehydrated air-dried cervical smears over conventional wet.fixed PAP smears: A comparative study.
    Indian J Pathol Microbiol. 2022;65:100-104.
    PubMed    
    Abstract available

  277. WANG W, Yang A, Zhang H, Li Y, et al
    Associations of RBC and Serum Folate Concentrations with Cervical Intraepithelial Neoplasia and High-Risk Human Papillomavirus Genotypes in Female Chinese Adults.
    J Nutr. 2022;152:466-474.
    PubMed    
    Abstract available

  278. MELLING GE, Conlon R, Pantazi P, Dellar ER, et al
    Confocal microscopy analysis reveals that only a small proportion of extracellular vesicles are successfully labelled with commonly utilised staining methods.
    Sci Rep. 2022;12:262.
    PubMed    
    Abstract available

  279. ZHENG N, Fu Y, Liu X, Zhang Z, et al
    Tumor microenvironment responsive self-cascade catalysis for synergistic chemo/chemodynamic therapy by multifunctional biomimetic nanozymes.
    J Mater Chem B. 2022;10:637-645.
    PubMed    
    Abstract available

  280. SUN L, Shan X, Dong Q, Wu C, et al
    Ultrasonic Elastography Combined with Human Papilloma Virus Detection Based on Intelligent Denoising Algorithm in Diagnosis of Cervical Intraepithelial Neoplasia.
    Comput Math Methods Med. 2021;2021:8066133.
    PubMed    
    Abstract available

  281. TEIXEIRA JC, Roteli-Martins CM
    HPV Vaccination and Screening with High-Performance Test: Brazilian Evidence.
    Rev Bras Ginecol Obstet. 2021;43:885-886.
    PubMed    


  282. MESSA L, Loregian A
    HPV-induced cancers: preclinical therapeutic advancements.
    Expert Opin Investig Drugs. 2022;31:79-93.
    PubMed    
    Abstract available

  283. SRIVASTAVA AN, Misra JS, Rizvi S
    Detection of human papillomavirus high-risk genotypes in rural women of Lucknow, North India.
    J Cancer Res Ther. 2021;17:1468-1472.
    PubMed    
    Abstract available

  284. JAIN BB, Adhikary T, Sadhukhan PC, Nandi A, et al
    Human papilloma virus infection of uterine cervix and spectrum of cervical pathology in human immunodeficiency virus/AIDS.
    J Cancer Res Ther. 2021;17:1462-1467.
    PubMed    
    Abstract available

  285. CARCEL C, Masia F, Marsollier-Ferrer C, de Tayrac R, et al
    [How I do... To simply expose myself without a uterine manipulator and to limit the risk of tumor dissemination during a hysterectomy for cancer?]
    Gynecol Obstet Fertil Senol. 2022;50:93-97.
    PubMed    


  286. EGLOFF C, Mergui JL, Uzan C, Canlorbe G, et al
    [Management of HPV-induced cervical lesions in immunosuppressed patients - Review of the literature].
    Gynecol Obstet Fertil Senol. 2022;50:82-92.
    PubMed    
    Abstract available

  287. BECKMANN MW, Stuebs FA, Vordermark D, Koch MC, et al
    The Diagnosis, Treatment, and Aftercare of Cervical Carcinoma.
    Dtsch Arztebl Int. 2021;118:806-812.
    PubMed    
    Abstract available

  288. WANG JY, Jiang MW, Li MY, Zhang ZH, et al
    Formononetin represses cervical tumorigenesis by interfering with the activation of PD-L1 through MYC and STAT3 downregulation.
    J Nutr Biochem. 2022;100:108899.
    PubMed    
    Abstract available

  289. MITRA A, MacIntyre DA, Paraskevaidi M, Moscicki AB, et al
    The vaginal microbiota and innate immunity after local excisional treatment for cervical intraepithelial neoplasia.
    Genome Med. 2021;13:176.
    PubMed    
    Abstract available

  290. CHEN Y, Wu X, Liu L
    Association between systemic lupus erythematosus and risk of cervical atypia: A meta-analysis.
    Lupus. 2021;30:2075-2088.
    PubMed    
    Abstract available

  291. SHETTY S, Shetty V, Badiger S, Shetty AK, et al
    An exploratory study of undergraduate healthcare student perspectives regarding human papillomavirus and vaccine intent in India.
    Womens Health (Lond). 2021;17:17455065211055304.
    PubMed    
    Abstract available

  292. HOSSEINI N, Shoja Z, Arashkia A, Khodadadi AH, et al
    Lineage analysis of human papillomavirus type 39 in cervical samples of Iranian women.
    Virol J. 2021;18:152.
    PubMed    
    Abstract available

  293. CHAVOSHPOUR-MAMAGHANI S, Shoja Z, Mollaei-Kandelous Y, Sharifian K, et al
    The prevalence of human herpesvirus 8 in normal, premalignant, and malignant cervical samples of Iranian women.
    Virol J. 2021;18:144.
    PubMed    
    Abstract available

  294. KAJIMINA KATUMBAYI JC, Muyulu NP, Zakayi PK, Lebwaze Massamba B, et al
    [Epidemiologic and histopathologic characteristics of 1280 uterine cervical cancers in Kinshasa].
    Gynecol Obstet Fertil Senol. 2022;50:53-61.
    PubMed    
    Abstract available

  295. CHENG A, Jiang Y, Wang T, Yu F, et al
    Energy restriction causes metaphase delay and chromosome mis-segregation in cancer cells.
    Cell Cycle. 2021;20:1195-1208.
    PubMed    
    Abstract available

  296. SHAMSEDDINE AA, Burman B, Lee NY, Zamarin D, et al
    Tumor Immunity and Immunotherapy for HPV-Related Cancers.
    Cancer Discov. 2021;11:1896-1912.
    PubMed    
    Abstract available

  297. SONG Z, Cui Y, Li Q, Deng J, et al
    The genetic variability, phylogeny and functional significance of E6, E7 and LCR in human papillomavirus type 52 isolates in Sichuan, China.
    Virol J. 2021;18:94.
    PubMed    
    Abstract available

  298. CAMPOS NG, Chaturvedi AK, Kreimer AR
    Real-World HPV Vaccine Effectiveness Studies: Guideposts for Interpretation of Current and Future Studies.
    J Natl Cancer Inst. 2021 Apr 20. pii: 6227604. doi: 10.1093.
    PubMed    


  299. NICOLAS-PARRAGA S, Torres M, Alemany L, Felix A, et al
    Human DNA decays faster with time than viral dsDNA: an analysis on HPV16 using pathology archive samples spanning 85 years.
    Virol J. 2021;18:65.
    PubMed    
    Abstract available

  300. LIN HY, Fu Q, Kao YH, Tseng TS, et al
    Antioxidants Associated with Oncogenic HPV Infection in women.
    J Infect Dis. 2021 Mar 18. pii: 6178356. doi: 10.1093.
    PubMed    
    Abstract available

  301. LI P, Liu Q, Li W, Liu Z, et al
    Characteristics of human papillomavirus infection among women with cervical cytological abnormalities in the Zhoupu District, Shanghai City, China, 2014-2019.
    Virol J. 2021;18:51.
    PubMed    
    Abstract available

  302. DEHLENDORFF C, Baandrup L, Kjaer SK
    Real-World Effectiveness of Human Papillomavirus Vaccination Against Vulvovaginal High-Grade Precancerous Lesions and Cancers.
    J Natl Cancer Inst. 2021;113:869-874.
    PubMed    
    Abstract available

  303. RAO JS, Zhang H, Kobetz E, Aldrich MC, et al
    Predicting DNA methylation from genetic data lacking racial diversity using shared classified random effects.
    Genomics. 2021;113.
    PubMed    
    Abstract available

  304. NARESH A, Hagensee M, Myers L, Cameron J, et al
    Association of Diet Quality and Dietary Components with Clinical Resolution of HPV.
    Nutr Cancer. 2021;73.
    PubMed    
    Abstract available

  305. DESHMUKH AA, Suk R, Shiels MS, Damgacioglu H, et al
    Incidence Trends and Burden of Human Papillomavirus-Associated Cancers Among Women in the United States, 2001-2017.
    J Natl Cancer Inst. 2021;113:792-796.
    PubMed    
    Abstract available

  306. CHANTZIANTONIOU N
    Back from the Future: Rational Accountabilities for Cytopathology in Pap Test Cervical Cancer Screening Arising from Covid19.
    Acta Cytol. 2022 Jan 28:1-5. doi: 10.1159/000521911.
    PubMed    


  307. REGAUER S, Reich O, Kashofer K
    HPV-negative Squamous Cell Carcinomas of the Cervix With Special Focus on Intraepithelial Precursor Lesions.
    Am J Surg Pathol. 2022;46:147-158.
    PubMed    
    Abstract available

  308. DICK S, Vink FJ, Heideman DAM, Lissenberg-Witte BI, et al
    Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping.
    Br J Cancer. 2021 Nov 6. pii: 10.1038/s41416-021-01614.
    PubMed    
    Abstract available

  309. EKANAYAKE WEERAMANGE C, Shu D, Tang KD, Batra J, et al
    Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
    Cancer. 2022 Feb 17. doi: 10.1002/cncr.34148.
    PubMed    
    Abstract available

  310. NG JKM, Li JJX, Lee JHS
    Smear detected cervicovaginal melanoma following negative screening-a cautionary tale of rapidly developing malignancy of the lower female genital tract.
    Cytopathology. 2021;32:819-822.
    PubMed    


  311. MAGRO A, Lyon R, Ellis KM, Tidy JA, et al
    Are we managing our patients correctly following treatment for cervical glandular intraepithelial neoplasia? A review of practice at the Jessop Wing Colposcopy Unit.
    Cytopathology. 2021;32:758-765.
    PubMed    
    Abstract available

  312. GUPTA P, Gupta N, Suri V, Rai B, et al
    Cytomorphological features of cervical small cell neuroendocrine carcinoma in SurePath liquid-based cervical samples.
    Cytopathology. 2021;32:813-818.
    PubMed    
    Abstract available

  313. NIKOLOPOULOS M, Athanasias P, Godfrey MAL, Nikolopoulos K, et al
    Cervical glandular neoplasia referrals and the diagnosis of adenocarcinoma in situ: Correlating cytology, colposcopy findings, and clinical outcomes.
    Cytopathology. 2021;32:751-757.
    PubMed    
    Abstract available

  314. CUSCHIERI K
    Risk adaptive triage in cervical screening: challenges and opportunities.
    Cytopathology. 2021;32:712-713.
    PubMed    


  315. KUMAR P, Gupta P, Dey P
    Cytodiagnosis of metastatic cervical low-grade endometrial stromal sarcoma presenting as bilateral adnexal masses.
    Diagn Cytopathol. 2021 Sep 28. doi: 10.1002/dc.24881.
    PubMed    


  316. TJALMA WAA, van Heerden J, Van den Wyngaert T
    If prophylactic HPV vaccination is considered in a woman with CIN2+, what is the value and should it be given before or after the surgical treatment?
    Eur J Obstet Gynecol Reprod Biol. 2022;269:98-101.
    PubMed    
    Abstract available

  317. LICHTER KE, Levinson K, Hammer A, Lippitt MH, et al
    Understanding cervical cancer after the age of routine screening: Characteristics of cases, treatment, and survival in the United States.
    Gynecol Oncol. 2022 Jan 31. pii: S0090-8258(22)00025.
    PubMed    
    Abstract available

  318. YAHATA H, Kodama K, Okugawa K, Hachisuga K, et al
    Long-term follow up after sentinel node biopsy alone for early-stage cervical cancer.
    Gynecol Oncol. 2022 Feb 9. pii: S0090-8258(22)00070.
    PubMed    
    Abstract available

  319. KO EM, Bekelman JE, Hicks-Courant K, Brensinger CM, et al
    Association of gynecologic oncology versus medical oncology specialty with survival, utilization, and spending for treatment of gynecologic cancers.
    Gynecol Oncol. 2021 Dec 20. pii: S0090-8258(21)01627.
    PubMed    
    Abstract available

  320. SWIFT BE, Maeda A, Bouchard-Fortier G
    Low incidence of venous thromboembolism after gynecologic oncology surgery: Who is at greatest risk?
    Gynecol Oncol. 2021 Dec 14. pii: S0090-8258(21)01637.
    PubMed    
    Abstract available

  321. BORCINOVA M, Ragosch V, Jarkovsky J, Bajsova S, et al
    Challenges in lower limb lymphoedema assessment based on limb volume change: Lessons learnt from the SENTIX prospective multicentre study.
    Gynecol Oncol. 2022;164:76-84.
    PubMed    
    Abstract available

  322. CHARGARI C, Arbyn M, Leary A, Abu-Rustum NR, et al
    Increasing global accessibility to high-level treatments for cervical cancers.
    Gynecol Oncol. 2021 Oct 26. pii: S0090-8258(21)01517.
    PubMed    
    Abstract available

  323. ARBYN M, Castle PE, Schiffman M, Wentzensen N, et al
    Meta-analysis of agreement/concordance statistics in studies comparing self- versus clinician-collected samples for HPV testing in cervical cancer screening.
    Int J Cancer. 2022 Feb 18. doi: 10.1002/ijc.33967.
    PubMed    
    Abstract available

  324. SPENCER JC, Campos NG, Burger EA, Sy S, et al
    Potential Effectiveness of a Therapeutic HPV Intervention Campaign in Uganda.
    Int J Cancer. 2021 Nov 6. doi: 10.1002/ijc.33867.
    PubMed    
    Abstract available

  325. GUSTINUCCI D, Benevolo M, Cesarini E, Mancuso P, et al
    Accuracy of Different Triage Strategies for HPV Positivity in an Italian Screening Population.
    Int J Cancer. 2021 Oct 27. doi: 10.1002/ijc.33858.
    PubMed    
    Abstract available

  326. VERHOEF L, Bleeker MCG, Polman N, Steenbergen RDM, et al
    Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV-positive women: results from a Dutch primary HPV-based screening cohort.
    Int J Cancer. 2021 Sep 24. doi: 10.1002/ijc.33820.
    PubMed    
    Abstract available

  327. WRIGHT TC JR, Stoler MH, Ranger-Moore J, Fang Q, et al
    Clinical Validation of p16/Ki-67 Dual-Stained Cytology Triage of HPV-Positive Women - Results from the IMPACT Trial.
    Int J Cancer. 2021 Sep 18. doi: 10.1002/ijc.33812.
    PubMed    
    Abstract available

  328. STANCZUK GA, Currie H, Forson W, Baxter G, et al
    Self-sampling as the principal modality for population based cervical screening: Five-year follow-up of the PaVDaG study.
    Int J Cancer. 2022;150:1350-1356.
    PubMed    
    Abstract available

  329. ZHANG Y, Huang Y, Luo S, Li L, et al
    Therapeutic strategy analysis of patients with advanced stage high-grade neuroendocrine cervical cancer: A real-world multicenter study.
    Int J Gynaecol Obstet. 2022 Feb 5. doi: 10.1002/ijgo.14125.
    PubMed    
    Abstract available

  330. TESKERECI G, Arslan UO, Oncel S
    The awareness levels of women on gynecological cancer in Turkey: A cross-sectional study.
    Int J Gynaecol Obstet. 2021 May 18. doi: 10.1002/ijgo.13745.
    PubMed    
    Abstract available

  331. TAWIAH A, Konney TO, Dassah ET, Visser LE, et al
    Determinants of Cervical Cancer Screening Uptake Among Women with Access to Free Screening: A Community-Based Study in Peri-Urban Ghana.
    Int J Gynaecol Obstet. 2022 Feb 25. doi: 10.1002/ijgo.14158.
    PubMed    
    Abstract available

  332. PEREZ MONTIEL CA, Varela Aguirre GJ
    Primary non-gestational choriocarcinoma of the uterine cervix.
    Int J Gynecol Cancer. 2022;32:111-112.
    PubMed    


  333. GORDHANDAS SB, Kahn R, Sassine D, Aviki EM, et al
    Gastric-type adenocarcinoma of the cervix in patients with Peutz-Jeghers syndrome: a systematic review of the literature with proposed screening guidelines.
    Int J Gynecol Cancer. 2022;32:79-88.
    PubMed    
    Abstract available

  334. DAIX M, Angeles MA, Leray H, Vergriete K, et al
    Anterior pelvic exenteration and laterally extended pelvic resection: a step by step procedure.
    Int J Gynecol Cancer. 2022;32:107-108.
    PubMed    


  335. DEVAJA O, Papadopoulos AJ, Bharathan R, Montalto SA, et al
    Sentinel lymph node biopsy alone in the management of early cervical carcinoma.
    Int J Gynecol Cancer. 2022;32:15-20.
    PubMed    
    Abstract available

  336. REGAUER S, Reich O, Kashofer K
    Correspondence on "Human papillomavirus-independent cervical cancer" by Fernandes et al.
    Int J Gynecol Cancer. 2022 Feb 15. pii: ijgc-2022-003368.
    PubMed    


  337. SALVO G, Ramalingam P, Bhosale P, Frumovitz M, et al
    Early-stage, high-grade neuroendocrine cervical carcinoma.
    Int J Gynecol Cancer. 2021;31:1179-1183.
    PubMed    


  338. NASIOUDIS D, Byrne M, Ko EM, Haggerty AF, et al
    Minimally invasive hysterectomy for stage IA cervical carcinoma: a survival analysis of the National Cancer Database.
    Int J Gynecol Cancer. 2021;31:1099-1103.
    PubMed    
    Abstract available

  339. NAVARRO AS, Angeles MA, Migliorelli F, Illac C, et al
    Comparison of SPECT-CT with intraoperative mapping in cervical and uterine malignancies.
    Int J Gynecol Cancer. 2021;31:679-685.
    PubMed    
    Abstract available

  340. MUALLEM MZ, Miranda A, Muallem J
    Nerve-sparing radical hysterectomy-Muallem technique with explanation of parametrium and paracolpium anatomy.
    Int J Gynecol Cancer. 2021;31:795-796.
    PubMed    


  341. VIVEROS-CARRENO D, Rodriguez J, Rendon Pereira GJ, Slama J, et al
    Fertility-sparing surgery after neo-adjuvant chemotherapy in women with cervical cancer larger than 4 cm: a systematic review.
    Int J Gynecol Cancer. 2022 Feb 24. pii: ijgc-2021-003297.
    PubMed    
    Abstract available

  342. MACCHIA G, Nardangeli A, Laliscia C, Fodor A, et al
    Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups.
    Int J Gynecol Cancer. 2022 Feb 22. pii: ijgc-2021-003237.
    PubMed    
    Abstract available

  343. MITTAL P, Chopra S, Charnalia M, Dora T, et al
    Patterns of relapse after adjuvant (chemo)radiation for cervical cancer in a phase III clinical trial (PARCER): an evaluation of updated NRG Oncology /RTOG target delineation guidelines.
    Int J Radiat Oncol Biol Phys. 2022 Feb 11. pii: S0360-3016(22)00153.
    PubMed    
    Abstract available

  344. LINDEGAARD JC, Petric P, Schmid MP, Nesvacil N, et al
    Prognostic implications of uterine cervical cancer regression during chemoradiation evaluated by the T-score in the multicenter XXX study.
    Int J Radiat Oncol Biol Phys. 2022 Feb 11. pii: S0360-3016(22)00151.
    PubMed    
    Abstract available

  345. KIM H, Lee YC, Benedict SH, Dyer B, et al
    Dose summation strategies for external beam radiation therapy and brachytherapy in gynecologic malignancy: a review from the NRG Oncology and NCTN medical physics subcommittees.
    Int J Radiat Oncol Biol Phys. 2021 Jun 17. pii: S0360-3016(21)00737.
    PubMed    
    Abstract available

  346. KIDD E, Harkenrider M, Damast S, Fields E, et al
    Improving Radiation Therapy for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2022;112:841-848.
    PubMed    


  347. ZHANG W, Wang C, Hu X, Lian Y, et al
    Inhibition of LDHA suppresses cell proliferation and increases mitochondrial apoptosis via the JNK signaling pathway in cervical cancer cells.
    Oncol Rep. 2022;47.
    PubMed    
    Abstract available

  348. METAXAS T, Kenfack B, Sormani J, Tincho E, et al
    Acceptability and safety of thermal ablation to prevent cervical cancer in sub-Saharan Africa.
    BMC Cancer. 2022;22:132.
    PubMed    
    Abstract available

  349. SINGH M, Jha RP, Shri N, Bhattacharyya K, et al
    Secular trends in incidence and mortality of cervical cancer in India and its states, 1990-2019: data from the Global Burden of Disease 2019 Study.
    BMC Cancer. 2022;22:149.
    PubMed    
    Abstract available

  350. BHAT A, Yadav J, Thakur K, Aggarwal N, et al
    Transcriptome analysis of cervical cancer exosomes and detection of HPVE6*I transcripts in exosomal RNA.
    BMC Cancer. 2022;22:164.
    PubMed    
    Abstract available

  351. LIU W, Jiang Q, Sun C, Liu S, et al
    Developing a 5-gene prognostic signature for cervical cancer by integrating mRNA and copy number variations.
    BMC Cancer. 2022;22:192.
    PubMed    
    Abstract available

  352. BULA AK, Lee F, Chapola J, Mapanje C, et al
    Perceptions of cervical cancer and motivation for screening among women in Rural Lilongwe, Malawi: A qualitative study.
    PLoS One. 2022;17:e0262590.
    PubMed    
    Abstract available

  353. KORN AK, Muzingwani L, O'Bryan G, Ensminger A, et al
    Cervical cancer screening and treatment, HIV infection, and age: Program implementation in seven regions of Namibia.
    PLoS One. 2022;17:e0263920.
    PubMed    
    Abstract available

  354. SEIFU B, Fikru C, Yilma D, Tessema F, et al
    Predictors of time to death among cervical cancer patients at Tikur Anbesa specialized hospital from 2014 to 2019: A survival analysis.
    PLoS One. 2022;17:e0264369.
    PubMed    
    Abstract available

  355. LEWIS S, Mphande M, Chibwana F, Gumbo T, et al
    Association of HIV status and treatment characteristics with VIA screening outcomes in Malawi: A retrospective analysis.
    PLoS One. 2022;17:e0262904.
    PubMed    
    Abstract available

  356. MIYAJI KT, Infante V, Picone CM, Levi JE, et al
    Human Papillomavirus (HPV) seroprevalence, cervical HPV prevalence, genotype distribution and cytological lesions in solid organ transplant recipients and immunocompetent women in Sao Paulo, Brazil.
    PLoS One. 2022;17:e0262724.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;